Pacific Biosciences of California PACB Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Pacific Biosciences of California’s reported figures.
Based on trailing twelve months.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's operating margin?
- Pacific Biosciences of California (PACB) reported operating margin of -83.3% in Q1 2026.
- How has Pacific Biosciences of California's operating margin changed year-over-year?
- Pacific Biosciences of California's operating margin increased by 84.6% year-over-year, from -539.4% to -83.3%.
- What is the long-term trend for Pacific Biosciences of California's operating margin?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's operating margin has grown at a 21.8% compound annual growth rate (CAGR), from -129% to -346.2%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.